Protective effects of vaccination with bovine leukemia virus (BLV) Tax DNA against BLV infection in sheep

Journal of Veterinary Medical Science

Volumn 65, Issue 11, 2003, Pages 1201-1205

  Usui, Tatsufumi ^a   Konnai, Satoru ^a   Tajima, Shigeru ^b   Watarai, Shinobu ^c   Aida, Yoko ^b   Ohashi, Kazuhiko ^a   Onuma, Misao ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b RIKEN   (Japan)

^c Osaka Prefecture University   (Japan)

Author keywords

BLV tax; DNA vaccine; Real time PCR

Indexed keywords

BOVINE LEUKEMIA VIRUS; OVIS ARIES;

CYTOKINE; DNA VACCINE; MESSENGER RNA; PRIMER DNA; TAX PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE LEUKEMIA VIRUS; COMPARATIVE STUDY; GENETICS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; POLYMERASE CHAIN REACTION; SHEEP; SHEEP DISEASE; VACCINATION; VIROLOGY;

ANIMALS; CYTOKINES; DELTARETROVIRUS INFECTIONS; DNA PRIMERS; GENE PRODUCTS, TAX; LEUKEMIA VIRUS, BOVINE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SHEEP; SHEEP DISEASES; VACCINATION; VACCINES, DNA;

EID: 1542784239     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.65.1201     Document Type: Article

References (32)

1. Brillowska, A., Dabrowski, S., Rulka, J., Kubis, P., Buzala, E. and Kur, J. 1999. Protection of cattle against bovine leukemia virus (BLV) infection could be attained by DNA vaccination. Acta. Biochim. Pol. 46: 971-976.
2. Derse, D. 1987. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. J. Virol. 61: 2462-2471.
3. Gregoriadis, G., Bacon, A., Caparros-Wanderley, W. and McCormack, B. 2002. A role for liposomes in genetic vaccination. Vaccine 20 (Suppl.) 5: B1-B9.
4. Gurunathan, S., Klinman, D. M. and Seder, R. A. 2000. DNA vaccines: Immunology, application, and optimization. Annu. Rev. Immunol. 18: 927-974.
5. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (Lond.) 348: 245-248.
6. Jeang, K. T. 2001. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: Cellular signaling through NF-kappa B. Cytokine Growth Factor Rev. 12: 207-217.
7. Kabeya, H., Ohashi, K. and Onuma, M. 2001. Host immune responses in the course of bovine leukemia virus infection. J. Vet. Med. Sci. 63: 703-708.
8. Kabeya, H., Ohashi, K., Oyunbileg, N., Nagaoka, Y., Aida, Y., Sugimoto, C., Yokomizo, Y. and Onuma, M. 1999. Up-regulation of tumor necrosis factor α mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection. Vet. Immunol. Immunopathol. 68: 255-265.
9. Kabeya, H., Ohashi, K., Sugimoto, C. and Onuma, M. 1999. Bovine leukaemia virus envelope peptides cause immunomodulation in BALB/c mice. Vet. Immunol. Immunopathol. 68: 39-48.
10. Kabeya, H., Ohashi, K., Sugimoto, C. and Onuma, M. 1999. Characterization of immune responses caused by bovine leukemia virus envelope peptides in sheep. J. Vet. Med. Sci. 61: 475-480.
11. + cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 3: 761-767.
12. Kannagi, M., Shida, H., Igarashi, H., Kuruma, K., Murai, H., Aono, Y., Maruyama, I., Osame, M., Hattori, T. and Inoko, H. 1992. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66: 2928-2933.
13. Kerkhofs, P., Gatot, J. S., Knapen, K., Mammerickx, M., Burny, A., Portetelle, D., Willems, L. and Kettmann, R. 2000. Long-term protection against bovine leukaemia virus replication in cattle and sheep. J. Gen. Virol. 81: 957-963.
14. Kettmann, R., Portetelle, D., Mammerickx, M., Cleuter, Y., Dekegel, D., Galoux, M., Ghysdael, J., Burny, A. and Chantrenne, H. 1976. Bovine leukemia virus: An exogenous RNA oncogenic virus. Proc. Natl. Acad. Sci. U. S. A. 73: 1014-1018.
15. Konnai, S., Takeshima, S., Tajima, S., Yin, S., Okada, K., Onuma, M. and Aida, Y. 2003. The influence of ovine MHC class II DRB1 alleles on immune response in bovine leukemia virus infection. Microbiol. Immunol. 47: 223-232.
16. Lee, J. T., Watarai, S., Kakidani, H., Onuma, M., Zhao, D. D. and Yasuda, T. 1997. Evaluation of cationic liposomes for delivery of diphtheria toxin A-chain gene to cells infected with bovine leukemia virus. J. Vet. Med. Sci. 59: 169-174.
17. Lew, D., Parker, S. E., Latimer, T., Abai, A. M., Kuwahara-Rundell, A., Doh, S. G., Yang, Z. Y., Laface, D., Gromkowski, S. H. and Nabel, G. J. 1995. Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6: 553-564.
18. Ohashi, T., Hanabuchi, S., Kato, H., Tateno, H., Takemura., F., Tsukahara, T., Koya, Y., Hasegawa, A., Masuda, T. and Kannagi, M. 2000. Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively tranferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine. J. Virol. 74: 9610-9616.
19. Ohishi, K., Kabeya, H., Amanuma, H. and Onuma, M. 1996. Induction of bovine leukaemia virus Env-specific Th-1 type immunity in mice by vaccination with short synthesized peptide-liposome. Vaccine 14: 1143-1148.
20. Ohishi, K., Suzuki, H., Yamamoto, T., Maruyama, T., Miki, K., Ikawa, Y., Numakunai, S., Okada, K., Ohshima, K. and Sugimoto, M. 1991. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: Association with cell-mediated immunity. J. Gen. Virol. 72: 1887-1892.
21. Ohishi, K., Suzuki, H., Yasutomi, Y., Onuma, M., Okada, K., Numakunai, S., Ohshima, K., Ikawa, Y. and Sugimoto, M. 1992. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: Their role in the suppression of BLV replication. Microbiol. Immunol. 36: 1317-1323.
22. Onuma, M., Watarai, S., Mikami, T. and Izawa, H. 1980. Cell fusion activity of bovine leukaemia virus. J. Gen. Virol. 48: 421-424.
23. Parker, C. E., Daenke, S., Nightingale, S. and Bangham, C. R. 1992. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188: 628-636.
24. Pyeon, D., O'Reilly, K. L. and Splitter, G. A. 1996. Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus. J. Virol. 70: 5706-5710.
25. Richmond, J. F. L., Lu, S., Santoro, J. C., Weng, J., Hu, S., Montefiori, D. C. and Robinson, H. L. 1998. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J. Virol. 72: 9092-9100.
26. Sakakibara, N., Kabeya, H., Ohashi, K., Sugimoto, C. and Onuma, M. 1998. Epitope mapping of bovine leukemia virus transactivator protein Tax. J. Vet. Med. Sci. 60: 599-605.
27. Scheerlinck, J. P., Casey, G., McWaters, P., Kelly, J., Woollard, D., Lightowlers, M. W., Tennent, J. M. and Chaplin, P. J. 2001. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Vaccine 19: 4053-4060.
28. Sentsui, H., Murakami, K., Inoshima, Y., Yokoyama, T. and Inumaru, S. 2001. Anti-viral effect of recombinant bovine interferon gamma on bovine leukaemia virus. Cytokine 16: 227-231.
29. Song, M., Lee, S., Suh, Y., Lee, K. and Sung, Y. 2000. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte response by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice. J. Virol. 74: 2920-2925.
30. Tajima, S. and Aida, Y. 2000. The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) Tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers. J. Virol. 74: 10939-10949.
31. Tana, Watarai, S., Onuma, M., Aida, Y., Kakidani, H., Kodama, H. and Yasuda, T. 1998. Antitumor effect of diphtheria toxin A-chain gene-containing cationic liposomes conjugated with monoclonal antibody directed to tumor-associated antigen of bovine leukemia cells. Jpn. J. Cancer Res. 89: 1202-1211.
32. Willems, L., Kerkhofs, P., Dequiedt, F., Portetelle, D., Mammerickx, M., Burny, A. and Kettmann, R. 1994. Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames. Proc. Natl. Acad. Sci. U. S. A. 91: 11532-11536.